Context Therapeutics (CNTX) Shares Outstanding (2020 - 2026)

Context Therapeutics has reported Shares Outstanding (Entity) for 7 years, with the latest figure at $91.9 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 2.42% year-over-year to $91.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $91.9 million (up 2.42% YoY) and the FY2025 annual result came in at $91.9 million, up 57.28% from the prior year.
• Shares Outstanding (Entity) was little changed at $91.9 million in Q1 2026 per CNTX's latest filing, from $91.9 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $91.9 million in Q3 2025 and troughed at $16.0 million in Q1 2022.
• A 5-year average of $46.3 million and a median of $16.0 million in 2022 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Entity) surged 4651.7% in 2022, then changed 0.0% in 2023.
• Over 5 years, Shares Outstanding (Entity) stood at $16.0 million in 2022, then changed by 0.0% to $16.0 million in 2023, then surged by 265.88% to $58.4 million in 2024, then surged by 57.28% to $91.9 million in 2025, then changed by 0.0% to $91.9 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $91.9 million, $91.9 million, and $91.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.